What is august bioservices?
Founded in 2017, August Bioservices operates as a specialized contract research and manufacturing organization (CRMO). The company provides a comprehensive suite of services, including rigorous pharmaceutical development and advanced manufacturing, tailored to the needs of the biotechnology and pharmaceutical sectors. By combining deep scientific expertise with a commitment to operational persistence, the firm serves as a critical partner for organizations navigating the complexities of drug development. Its headquarters in Nashville, Tennessee, serves as the hub for its multidisciplinary team of experts who focus on delivering ingenuity and precision in every project phase.
How much funding has august bioservices raised?
august bioservices has raised a total of $88.6M across 2 funding rounds:
Series A
$23.6M
Series B
$65M
Series A (2021): $23.6M with participation from Oak HC/FT and Polaris Partners
Series B (2022): $65M led by Oak HC/FT and Polaris Partners
Key Investors in august bioservices
Oak HC/FT
A premier venture growth-equity fund that invests in healthcare information and financial services technology, providing strategic counsel and board-level participation to drive industry transformation.
Polaris Partners
A venture capital firm specializing in backing transformational companies in the biotech and healthcare sectors, offering deep operational expertise and resources to foster innovation.
What's next for august bioservices?
With the recent infusion of capital, August Bioservices is poised to scale its manufacturing capabilities and deepen its research competencies. The strategic backing from institutional investors suggests a focus on long-term value creation and market leadership in the life sciences sector. Future initiatives will likely center on expanding facility capacity, integrating cutting-edge analytical technologies, and strengthening partnerships with emerging biotech firms. As the company continues to execute its growth strategy, it remains focused on maintaining the high standards of integrity and scientific rigor that have defined its reputation since inception.
See full august bioservices company page
